首页 | 本学科首页   官方微博 | 高级检索  
     


Liver resection after Y-90 radioembolization: a systematic review and meta-analysis of perioperative morbidity and mortality
Affiliation:1. Department of Surgery, Division of Surgical Oncology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA;2. Department of Biostatistics, University of Nebraska Medical Center College of Public Health, Omaha, NE, 68198, USA
Abstract:BackgroundData on morbidity and mortality following liver resection after radioembolization (Y90) are limited and controversial. Therefore, the perioperative morbidity and mortality of liver resections after Y90 treatment were investigated with systematic review and meta-analysis.MethodsA PubMed search was conducted to identify studies of liver resection after previous Y90 treatment. Systematic review and meta-analysis for perioperative morbidity and mortality were perfomed using the 2009 PRISMA guidelines and STATA 16.1 software.ResultsA total of 16 studies reporting on 276 patients who underwent liver resection after Y90 met the inclusion criteria and were included in the meta-analysis. Meta-analysis of 30-day mortality rates yielded pooled mortality of 0.5% (95% CI 0.0–3.2%). Six studies (155 patients) reported a pooled 90-day mortality of 3.0% (95% CI 0.3–7.4%). The median time to resection after Y90 ranged from 2 to 12.5 months in various studies. In all studies where the median resection was undertaken eight or more months after Y90, zero 30-day mortality was reported. A meta-analysis of overall grade 3 or higher morbidity noted a rate of 26% (95% CI 16–37%).ConclusionsLiver resection after Y90 may be safe in very well selected patients. Delaying resection after Y90 may further decrease mortality.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号